DNA encoding antibody molecules which bind IL-17A and IL-17F
The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
1. An isolated DNA encoding the heavy chain variable domain and the light chain variable domain of a neutralising antibody which binds human IL-17A and human IL-17F, wherein the heavy chain variable domain comprises the sequence given in SEQ ID NO:9 and the light chain variable domain comprises the sequence given in SEQ ID NO:7, or encoding the heavy chain and the light chain of said antibody, wherein the heavy chain comprises the sequence given in SEQ ID NO:15 and the light chain comprises the sequence given in SEQ ID NO: 11.
2. A cloning or expression vector comprising the DNA according to claim 1 .
3. The vector according to claim 2 wherein the DNA comprises the sequences given in SEQ ID NO:13 and SEQ ID NO:17.
4. A cultured host cell comprising one or more cloning or expression vectors according to claim 2 or claim 3 .
5. An isolated DNA encoding the light chain variable domain of a neutralising antibody which binds human IL-17A and human IL-17F, wherein the variable domain of the light chain comprises the sequence given in SEQ ID NO:7.
6. A cloning or expression vector comprising the DNA according to claim 5 .
7. The vector according to claim 6 , wherein the DNA comprises the sequence given in SEQ ID NO:13.
8. A cultured host cell comprising one or more cloning or expression vectors according to claim 6 or claim 7 .
9. A process for the production of an antibody that binds human IL-17A and human IL-17F, and is encoded by a DNA comprising the sequences of SEQ ID NO:13 and 17, comprising culturing a host cell comprising an expression vector comprising said DNA under conditions suitable for expression of the antibody and isolating the antibody.